Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiqi Deng

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Biopharmaceutical Statistics|June 26, 2019
Applying CHW method to 2-in-1 design: gain or lose?Xiaofei Bai, Qiqi Deng
Journal of Biopharmaceutical Statistics|September 29, 2020
Multiplicity issues for platform trials with a shared control armXiaofei Bai, Qiqi Deng, Dacheng Liu
Statistics in Medicine|June 22, 2018
Dynamic development paths for expanding a proof-of-concept study to explore dose rangeQiqi Deng, Xiaofei Bai, Naitee Ting
Scientific Data|February 25, 2026
SexTumorDB: a comprehensive resource of sex-dependent tumor landscape at single-cell resolutionRuya Sun, Qiqi Deng, Di Wang
Contemporary Clinical Trials|June 7, 2020
Extensions of the 2-in-1 adaptive designCong Chen, Wen Li, Qiqi Deng
Journal of Biopharmaceutical Statistics|June 6, 2024
Conditional bias adjusted estimator of treatment effect in 2-in-1 adaptive designXiaofei Bai, Qiqi Deng, Wen Li
Pharmaceutical Statistics|June 24, 2020
Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug developmentYaoshi Wu, Jianan Hui, Qiqi Deng
Statistics in Medicine|December 1, 2023
Bayesian hierarchical modeling in interim futility analysis for two parallel clinical trialsHao Li, Dooti Roy, Qiqi Deng
Therapeutic Innovation & Regulatory Science|May 24, 2021
Proof of Concept: Drug Selection? Or Dose Selection? Thoughts on Multiplicity IssuesQian H Li, Qiqi Deng, Naitee Ting
Contemporary Clinical Trials|February 23, 2025
The modified combo i3 + 3 design for novel-novel combination dose-finding trials in oncologyJiaxin Liu, Shijie Yuan, Qiqi Deng, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Biopharmaceutical Statistics|June 26, 2019
Applying CHW method to 2-in-1 design: gain or lose?Xiaofei Bai, Qiqi Deng
Journal of Biopharmaceutical Statistics|September 29, 2020
Multiplicity issues for platform trials with a shared control armXiaofei Bai, Qiqi Deng, Dacheng Liu
Statistics in Medicine|June 22, 2018
Dynamic development paths for expanding a proof-of-concept study to explore dose rangeQiqi Deng, Xiaofei Bai, Naitee Ting
Scientific Data|February 25, 2026
SexTumorDB: a comprehensive resource of sex-dependent tumor landscape at single-cell resolutionRuya Sun, Qiqi Deng, Di Wang
Contemporary Clinical Trials|June 7, 2020
Extensions of the 2-in-1 adaptive designCong Chen, Wen Li, Qiqi Deng
Journal of Biopharmaceutical Statistics|June 6, 2024
Conditional bias adjusted estimator of treatment effect in 2-in-1 adaptive designXiaofei Bai, Qiqi Deng, Wen Li
Pharmaceutical Statistics|June 24, 2020
Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug developmentYaoshi Wu, Jianan Hui, Qiqi Deng
Statistics in Medicine|December 1, 2023
Bayesian hierarchical modeling in interim futility analysis for two parallel clinical trialsHao Li, Dooti Roy, Qiqi Deng
Therapeutic Innovation & Regulatory Science|May 24, 2021
Proof of Concept: Drug Selection? Or Dose Selection? Thoughts on Multiplicity IssuesQian H Li, Qiqi Deng, Naitee Ting
Contemporary Clinical Trials|February 23, 2025
The modified combo i3 + 3 design for novel-novel combination dose-finding trials in oncologyJiaxin Liu, Shijie Yuan, Qiqi Deng, et al.
Pageof 5